TARGETMOL CHEMICALS - Products
Offer over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, and novel life-science kits for scientific use.
| Product | Description | |
|---|---|---|
| Golden Scaffold Library | Diversity: Selected from 1, 600, 000 drug-like compounds, 10000 compounds representing 5000 scaffolds selected from a large drug-like chemical source?- Drug-likeness: filtering out reactive, toxic and otherwise undesirable structural motifs, and removing compounds that demonstrate a broad promiscuous activity (PAINS); - Strict quality control: more than 90% purity for each member with HNMR/LCMS validation?- Cost effective: Liquid small package is available. (Can be purchased together with Mini scaffolds library?forming a diversity library with more broad coverage. ). Uses: Scientific use. Product Category: L5610. Categories: Golden Scaffold Libraries. |  |
| GPCR Compound Library | A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; - Potential to find new GPCR drug candidates by screening against orphan GPCRs; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Targets include 5-HT receptor, dopamine receptor, opioid receptor, adrenergic receptor, mGluR, Cannabinoid receptor, ETA-receptor, etc; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L1500. Categories: GPCR Compounds Libraries. | |
| GPCR Compound Library Plus | Quantity: well-chosen 338 GPCR targeting compounds with unique structures; - High bioactivity: All compounds with IC50 below 3. 5 μM; - Targets include 21 various GPCR subtypes; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - HNMR/LCMS validated to ensure high purity and quality; - A powerful tool for GPCR drug development and target identification. Uses: Scientific use. Product Category: L1580. Categories: GPCR Compounds Libraries Plus. | |
| GPR34 receptor antagonist | GPR34 receptor antagonist Inhibitor. Uses: Scientific use. Product Category: T8848. CAS No. 907952-06-1. | |
| GSK126 | GSK126 Inhibitor. Uses: Scientific use. Product Category: T2079. CAS No. 1346574-57-9. | |
| GSK1324726A | GSK1324726A Inhibitor. Uses: Scientific use. Product Category: T6021. CAS No. 1300031-52-0. | |
| GSK256073 | GSK256073 Inhibitor. Uses: Scientific use. Product Category: T15432. CAS No. 862892-90-8. | |
| GSK 650394 | GSK 650394 Inhibitor. Uses: Scientific use. Product Category: T2622. CAS No. 890842-28-1. | |
| GSK805 | GSK805 Inhibitor. Uses: Scientific use. Product Category: T7388. CAS No. 1426802-50-7. | |
| GSK-J4 | GSK-J4 Inhibitor. Uses: Scientific use. Product Category: T3100. CAS No. 1373423-53-0. | |
| GsMTx4 TFA | GsMTx4 TFA Inhibitor. Uses: Scientific use. Product Category: TP1300. CAS No.: | |
| Gut Microbial Metabolite Library | A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS. Uses: Scientific use. Product Category: L2540. Categories: Gut Microbial Metabolite Libraries. | |
| GW4869 | GW4869 Inhibitor. Uses: Scientific use. Product Category: T3640. CAS No. 6823-69-4. | |
| Gymnemic acid | Gymnemic acid Inhibitor. Uses: Scientific use. Product Category: TN1718. CAS No. 122168-40-5. | |
| Harpagide | Harpagide Inhibitor. Uses: Scientific use. Product Category: T6S2024. CAS No. 6926-8-5. | |
| Hematonosis Compound Library | A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); - Effective tool for research in functions of the hematologic system and related diseases, such as hemophilia, leukemia, β-thalassemia; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - NMR and HPLC/LCMS validated to ensure high purity and quality. Uses: Scientific use. Product Category: L8400. Categories: Hematonosis Compounds Libraries. | |
| Hematopoietic Toxicity Compound Library | A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; - Targets include HDAC, PPAR, DNA Alkylating, EGFR, etc. ; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L3100. Categories: Hematopoietic Toxicity Compounds Libraries. | |
| Heparin | Heparin Inhibitor. Uses: Scientific use. Product Category: T6531. CAS No. 9041-8-1. | |
| HIF-1 Signaling Pathway Compound Library | A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies?- Covers PI3K-AKT, MAPK, Ubiquitination signaling pathways and targets such as HIF, HIF Prolyl-Hydroxylase, E1/E2/E3 Enzyme, PI3K, MAPK, Proteasome, etc. - Part of them are in clinical trial phase or FDA approved?- Detailed compound information with structure, target, and biological activity description?- NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L8500. Categories: HIF-1 Signaling Pathway Compounds Libraries. | |
| High Solubility 3D Diversity Fragment Library | Traditional drug research and development are mainly based on natural active products or screening new drugs from existing compound data, but this method is highly random, blind, and inefficient. Medicinal chemists subsequently developed high-throughput screening (HTS) methods for drug discovery. Many pharmaceutical companies have also established compound libraries containing millions of small molecules and discovered many drug candidates. However, in drug screening with complex targets, HTS has been repeatedly frustrated. It is difficult to screen high-potential compounds, or the screened compounds have high false positives and poor drug-like properties. In this context, Fragment-based drug design (FBDD) came into being. Organic synthesis can transform miniature hits into effective lead compounds. The deficiencies in the current screening of compound libraries usually result in the need for a large amount of synthetic investment to achieve multi-directional fragment growth, which limits the efficiency of the mini-fragment hit modification process. To meet this challenge, we designed a library of highly soluble 3D structural diversity fragments. The utility of X-ray-based fragment screening and the ability to achieve rapid analog synthesis: Uses: Scientific use. Product Category: L7850. Categories: High Solubility 3D Diversity Fragment Libraries. | |
| High Solubility FragLite Fragment Library | The theoretical basis of FBDD is to select favorable fragment combinations or extensions to obtain new drug molecules, with a higher probability of obtaining highly active drug candidates. Compared with the screening of millions of macromolecules, thousands of fragment molecules can be combined to form millions of drug structures, which are easier to collect and manage. In addition, fragments have smaller molecular weights, relatively higher solubility, and easier structural optimization. The potential of over-the-counter medicine is higher. The FragLites identify productive drug-like interactions, which are identified sensitively and unambiguously by X-ray crystallography, exploiting the anomalous scattering of the halogen substituent. This mapping of protein interaction surfaces provides an assessment of druggability and can identify efficient start points for the de novo design of hit molecules incorporating the interacting motifs. Combine fragments from FragLites to generate fragment lead compounds: Uses: Scientific use. Product Category: L7840. Categories: High Solubility FragLite Fragment Libraries. | |
| High Solubility Fragment Library | More diversity: structurally diverse, medicinally active, and unique chemistry (strong IP potential); - More opportunity for further scaffold modification; - Attractively priced. Uses: Scientific use. Product Category: L7800. Categories: High Solubility Fragment Libraries. | |
| High Solubility Micro Fragment Library | The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. Uses: Scientific use. Product Category: L7820. Categories: High Solubility Micro Fragment Libraries. | |
| High Solubility Pharmacophore Fragment Library | The theoretical basis of FBDD is to select favorable fragment combinations or extensions to obtain new drug molecules, with a higher probability of obtaining highly active drug candidates. Compared with the screening of millions of macromolecules, thousands of fragment molecules can be combined to form millions of drug structures, which are easier to collect and manage. In addition, fragments have smaller molecular weights, relatively higher solubility, and easier structural optimization. The potential of over-the-counter medicine is higher. We analyzed the key interactions discovered by target protein hot spots to derive the fragment pharmacophore represented by the fragment-protein complex available in the PDB. Using this information, we designed a set of minimal diversified commercial fragments, covering most experiments combined with pharmacophore, used to identify the starting point of the fragment for drug discovery targets. Uses: Scientific use. Product Category: L7830. Categories: High Solubility Pharmacophore Fragment Libraries. | |
| High Solubility Polyfunctional Group Fragment Library | Traditional drug research and development are mainly based on natural active products or screening new drugs from existing compound data, but this method is highly random, blind, and inefficient. Medicinal chemists subsequently developed high-throughput screening (HTS) methods for drug discovery. Many pharmaceutical companies have also established compound libraries containing millions of small molecules and discovered many drug candidates. However, in drug screening with complex targets, HTS has been repeatedly frustrated. It is difficult to screen high-potential compounds, or the screened compounds have high false positives and poor drug-like properties. In this ... are easier to collect and manage. In addition, fragments have smaller molecular weights, relatively higher solubility, and easier structural optimization. The potential of over-the-counter medicine is higher. The high solubility multifunctional fragment library is designed by analyzing the spatial stability of all commercially available fragments and selecting a chemically diverse subset. In order to enhance the diversity of the compound library, we carefully selected some additional saturated heterocyclic compounds to supplement the compound library. Uses: Scientific use. Product Category: L7810. Categories: High Solubility Polyfunctional Group Fragment Libraries. | |
| Histamine & Melatonin Receptor-Targeted Library | A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; - Bioactivity and safety confirmed by pre-clinical research and clinical trials; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L3300. Categories: Histamine & Melatonin Receptor-Targeted Libraries. | |
| Histone Modification Compound Library | A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L3500. Categories: Histone Modification Compounds Libraries. | |
| HJC0152 | HJC0152 Inhibitor. Uses: Scientific use. Product Category: T4234. CAS No. 1420290-99-8. | |
| Homoeriodictyol | Homoeriodictyol Inhibitor. Uses: Scientific use. Product Category: TN1740. CAS No. 446-71-9. | |
| Human Endogenous Metabolite Library | A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; - Effective tool for research in endogenous metabolism-related diseases, exploring the tumorigenesis, and drug discovery; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2500. Categories: Human Endogenous Metabolite Libraries. | |
| Human Metabolite Library | A unique collection of 4532 human metabolites for high-throughput, high-content screening. - An effective tool for studying human metabolic diseases, exploring the pathogenesis of cancer and finding new drugs. - Some compounds have been marketed or entered the clinical phase, which ensured low bio-toxicity and high bio-activity. - Structural diversity, significant drug potency and cell permeability. - Detailed specifications, description of compound structures, activity, etc. - Various detection techniques such as NMR, HPLC/LCMS to ensure correct structure and high purity of the product and reduce false positives. Uses: Scientific use. Product Category: L2570. Categories: Human Metabolite Libraries. | |
| Hygrovetine | Hygrovetine Inhibitor. Uses: Scientific use. Product Category: T1022. CAS No. 31282-04-9. | |
| IACS-010759 | IACS-010759 Inhibitor. Uses: Scientific use. Product Category: T5337. CAS No. 1570496-34-2. | |
| IBMX | IBMX Inhibitor. Uses: Scientific use. Product Category: T1713. CAS No. 28822-58-4. | |
| Ibrutinib | Ibrutinib Inhibitor. Uses: Scientific use. Product Category: T1835. CAS No. 936563-96-1. | |
| Icariside I | Icariside I Inhibitor. Uses: Scientific use. Product Category: T3808. CAS No. 56725-99-6. | |
| ICG001 | ICG001 Inhibitor. Uses: Scientific use. Product Category: T2237. CAS No. 847591-62-2. | |
| Imidazole ketone erastin | Imidazole ketone erastin Inhibitor. Uses: Scientific use. Product Category: T5523. CAS No. 1801530-11-9. | |
| Immunology/Inflammation Compound Library | A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. - Bioactivity and safety confirmed by clinical research and trials, some of which are FDA approved; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L4700. Categories: Immunology/Inflammation Compounds Libraries. | |
| Immuno-Oncology Compound Library | A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening?- Targets include PD-1/PD-L1, HER2, STAT3, CTLA4, IDO, STING, CCR, CXCR, TLR, etc. - Detailed compound information with structure, target, and biological activity description?- NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2170. Categories: Immuno-Oncology Compounds Libraries. | |
| Inavolisib | Inavolisib Inhibitor. Uses: Scientific use. Product Category: T15375. CAS No. 2060571-02-8. | |
| Infliximab | Infliximab Inhibitor. Uses: Scientific use. Product Category: T9921. CAS No. 170277-31-3. | |
| Inhibitor Library | A unique collection of 5700 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Covers various major targets including MAPK, PI3K, JAK, HDAC, VEGFR, CDK, etc. ; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2000. Categories: Inhibitor Libraries. | |
| Ion Channel Inhibitor Library | A unique collection of 946 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Targets include potassium channel, calcium channel, sodium channel, Proton pump, etc; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2300. Categories: Ion Channel Inhibitor Libraries. | |
| Ipilimumab | Ipilimumab Inhibitor. Uses: Scientific use. Product Category: T9906. CAS No. 477202-00-9. | |
| Isoginkgetin | Isoginkgetin Inhibitor. Uses: Scientific use. Product Category: T4S21320. CAS No. 548-19-6. | |
| Isoliensinine | Isoliensinine Inhibitor. Uses: Scientific use. Product Category: T5S1103. CAS No. 6817-41-0. | |
| JAK-STAT Compound Library | A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; - Effective tool for studying the JAK/STAT targets; - Bioactivity and safety confirmed by pre-clinical research and clinical trials; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L3700. Categories: JAK-STAT Compounds Libraries. | |
| JIB-04 | JIB-04 Inhibitor. Uses: Scientific use. Product Category: T1868. CAS No. 199596-05-9. | |
| JPH203 | JPH203 Inhibitor. Uses: Scientific use. Product Category: TQ0081. CAS No. 1037592-40-7. | |
| JQ1 | JQ1 Inhibitor. Uses: Scientific use. Product Category: T2110. CAS No. 1268524-70-4. | |
| JSH-150 | JSH-150 Inhibitor. Uses: Scientific use. Product Category: T8484. CAS No. 2247481-21-4. | |
| Kinase Inhibitor Library | A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; - Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA; - Targets include MAPK, PI3K, JAK, STAT, CDK, MEK, Insulin/IGF receptors, CaM Kinease II, PKA, JNK, PKC, RAF, EGFR, SAPK, GSK, MLCK, Src-family, IKK, PDGFR, VEGFR, etc; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L1600. Categories: Kinase Inhibitor Libraries. | |
| KPT9274 | KPT9274 Inhibitor. Uses: Scientific use. Product Category: T4354. CAS No. 1643913-93-2. | |
| L524-0366 | L524-0366 Inhibitor. Uses: Scientific use. Product Category: T8570. CAS No. 951612-19-4. | |
| Laduviglusib | Laduviglusib Inhibitor. Uses: Scientific use. Product Category: T2310. CAS No. 252917-06-9. | |
| Lanosterol | Lanosterol Inhibitor. Uses: Scientific use. Product Category: T4970. CAS No. 79-63-0. | |
| Larazotide | Larazotide Inhibitor. Uses: Scientific use. Product Category: T15711. CAS No. 881851-50-9. | |
| Lats-IN-1 | Lats-IN-1 Inhibitor. Uses: Scientific use. Product Category: T9053. CAS No. 1424635-83-5. | |
| LCL161 | LCL161 Inhibitor. Uses: Scientific use. Product Category: T2080. CAS No. 1005342-46-0. | |
| Leupeptin | Leupeptin Inhibitor. Uses: Scientific use. Product Category: T6564. CAS No. 103476-89-7. | |
| LGD-6972 | LGD-6972 Inhibitor. Uses: Scientific use. Product Category: T11845. CAS No. 1207989-09-0. | |
| Lipid Metabolism Compound Library | A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). - Covers several important targets, key components in lipid metabolism pathway, such as Acetyl-CoA Carboxylase?Acyltransferase?cholesteryl ester transfer protein (CETP)?FAAH?Fatty Acid Synthase (FASN)?HMG-CoA Reductase (HMGCR), etc. - Detailed compound information with structure, target, and biological activity description. - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2510. Categories: Lipid Metabolism Compounds Libraries. | |
| Lipopolysaccharides | Lipopolysaccharides Inhibitor. Uses: Scientific use. Product Category: T11855. CAS No.: | |
| Liproxstatin-1 | Liproxstatin-1 Inhibitor. Uses: Scientific use. Product Category: T2376. CAS No. 950455-15-9. | |
| Liraglutide | Liraglutide Inhibitor. Uses: Scientific use. Product Category: T6876. CAS No. 204656-20-2. | |
| Lisuride | Lisuride Inhibitor. Uses: Scientific use. Product Category: T8775. CAS No. 19875-60-6. | |
| LM11A-31 | LM11A-31 Inhibitor. Uses: Scientific use. Product Category: T11861. CAS No. 1243259-19-9. | |
| LNP023 | LNP023 Inhibitor. Uses: Scientific use. Product Category: T9189. CAS No. 1646321-63-2. | |
| LRRK2-IN-1 | LRRK2-IN-1 Inhibitor. Uses: Scientific use. Product Category: T2246. CAS No. 1234480-84-2. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.